Literature DB >> 4318526

Effect of cholestyramine on the absorption of vitamin D3 and calcium.

W G Thompson, G R Thompson.   

Abstract

The absorption of 10 mug doses of vitamin D(3)-(3)H in rats was found to be decreased by the addition of cholestyramine to the diet in an amount sufficient to cause steatorrhoea. Studies in vitro suggested that the effect of cholestyramine was due to its known ability to bind bile salts and thus disrupt micelles containing vitamin D. The absorption of 1 mg (47)calcium chloride was similar in both control and cholestyramine-fed rats, whether estimated by the whole body counting or the faecal excretion technique. These findings show that the administration of cholestyramine causes a reduction in the absorption of vitamin D(3)-(3)H but not of radiocalcium.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4318526      PMCID: PMC1552980          DOI: 10.1136/gut.10.9.717

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  ENHANCEMENT OF CALCIUM ABSORPTION IN MAN BY A BILE ACID SEQUESTRANT.

Authors:  A M Briscoe; C Ragan
Journal:  Am J Clin Nutr       Date:  1963-11       Impact factor: 7.045

2.  THE LONG TERM USE OF CHOLESTYRAMINE IN THE TREATMENT OF PRIMARY BILIARY CIRRHOSIS.

Authors:  F SCHAFFNER; F M KLION; A J LATUFF
Journal:  Gastroenterology       Date:  1965-03       Impact factor: 22.682

3.  The behavior and solubility of monoglycerides in dilute, micellar bile-salt solution.

Authors:  A F HOFMANN
Journal:  Biochim Biophys Acta       Date:  1963-06-18

4.  Xanthomatous biliary cirrhosis treated with cholestyramine. A bile-acid-adsorbing resin.

Authors:  R E VISINTINE; G D MICHAELS; G FUKAYAMA; J CONKLIN; L W KINSELL
Journal:  Lancet       Date:  1961-08-12       Impact factor: 79.321

5.  Relief of the pruritus of jaundice with a bile-acid sequestering resin.

Authors:  J B CAREY; G WILLIAMS
Journal:  JAMA       Date:  1961-05-06       Impact factor: 56.272

6.  The role of bile in calcium absorption.

Authors:  F W LENGEMANN; J W DOBBINS
Journal:  J Nutr       Date:  1958-09-10       Impact factor: 4.798

7.  Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption.

Authors:  G R Thompson; B Lewis; C C Booth
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

8.  Right upper quadrant calcification in a patient receiving long-term cholestyramine therapy for primary biliary cirrhosis.

Authors:  R F Wells; J H Knepshield; C Davis
Journal:  Am J Dig Dis       Date:  1968-01

9.  The interaction between cholestyramine and drugs.

Authors:  D G Gallo; K R Bailey; A L Sheffner
Journal:  Proc Soc Exp Biol Med       Date:  1965-10

10.  Bile salts and calcium absorption.

Authors:  D D Webling; E S Holdsworth
Journal:  Biochem J       Date:  1966-09       Impact factor: 3.857

View more
  12 in total

1.  The effect of cholestyramine on intestinal absorption.

Authors:  R J West; J K Lloyd
Journal:  Gut       Date:  1975-02       Impact factor: 23.059

Review 2.  Vitamin D deficient states. Pathophysiology and treatment.

Authors:  M D Jacobs
Journal:  West J Med       Date:  1979-10

3.  Effect of cholestyramine on absorption of 3H digoxin in rats.

Authors:  W G Thompson
Journal:  Am J Dig Dis       Date:  1973-10

4.  Role of the duodenum in vitamin D3 absorption in man.

Authors:  D Hollander; S J Rosenstreich; W Volwiler
Journal:  Am J Dig Dis       Date:  1971-02

Review 5.  Cholestyramine.

Authors:  W G Thompson
Journal:  Can Med Assoc J       Date:  1971-02-20       Impact factor: 8.262

Review 6.  Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease.

Authors:  J E Compston
Journal:  Gut       Date:  1986-09       Impact factor: 23.059

7.  Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease.

Authors:  R G Long; E Meinhard; R K Skinner; Z Varghese; M R Wills; S Sherlock
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

8.  Vitamin D deficiency, osteomalacia, and primary biliary cirrhosis. Response to orally administered vitamin D3.

Authors:  M Davies; E B Mawer; H J Klass; G A Lumb; J L Berry; T W Warnes
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

9.  Vitamin D prophylaxis and osteomalacia in chronic cholestatic liver disease.

Authors:  J E Compston; J P Crowe; I P Wells; L W Horton; D Hirst; A L Merrett; J S Woodhead; R Williams
Journal:  Dig Dis Sci       Date:  1980-01       Impact factor: 3.199

10.  Alterations in calcium, magnesium, iron, and zinc metabolism by dietary cholestyramine.

Authors:  D W Watkins; R Khalafi; M M Cassidy; G V Vahouny
Journal:  Dig Dis Sci       Date:  1985-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.